Review
doi: 10.1055/s-0034-1387450.
Epub 2014 Nov 25.
[Antifibrotic treatment]
[Article in
German]
Affiliations
- PMID: 25423462
- DOI: 10.1055/s-0034-1387450
Item in Clipboard
Review
[Antifibrotic treatment]
[Article in
German]
Dtsch Med Wochenschr.
2014 Dec.
No abstract available
Similar articles
-
Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.Thorax. 2014 Sep;69(9):791-2. doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4. Thorax. 2014. PMID: 24996636 No abstract available.
-
Pirfenidone for idiopathic pulmonary fibrosis.Lancet. 2011 May 21;377(9779):1727-9. doi: 10.1016/S0140-6736(11)60546-1. Epub 2011 May 13. Lancet. 2011. PMID: 21571363 No abstract available.
-
Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.N Engl J Med. 2015 Mar 26;372(13):1189-91. doi: 10.1056/NEJMp1500526. N Engl J Med. 2015. PMID: 25806913 No abstract available.
-
Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis.South Med J. 2017 Jun;110(6):393-398. doi: 10.14423/SMJ.0000000000000655. South Med J. 2017. PMID: 28575896 Review.
-
Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?Drugs Aging. 2017 Sep;34(9):647-653. doi: 10.1007/s40266-017-0488-0. Drugs Aging. 2017. PMID: 28861727 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
